Quick summary: PMS-Duloxetine 60 mg: Exceeds acceptable interim intake limit for N-nitroso-duloxetine (NDLX). Date: 2024-04-16.
Public recall detail
PMS-Duloxetine 60 mg: Exceeds acceptable interim intake limit for N-nitroso-duloxetine (NDLX)
2024-04-16
Recall
Safety notice
Quick summary
Recommended action
Recommended action: compare your product with the official notice and follow the instructions published by the official source.
Recall details
Quick summary: PMS-Duloxetine 60 mg: Exceeds acceptable interim intake limit for N-nitroso-duloxetine (NDLX). Date: 2024-04-16.
Official details
Affected product details
Structured information extracted from the official recall notice. Confirm the identifiers and instructions in the original notice.
BrandPharmascience Inc., PMS-Duloxetine
ProductPMS-Duloxetine 60 mg
IssueHealth products - Product quality
Recall classType I
IdentificationRA-75398
Affected products
BrandPMS-Duloxetine
ProductPMS-Duloxetine 60 mg - 100 capsules and blisters of 30 capsules
DIN / NPN / authorizationDIN 02429454
Lot642678; 645166; 646571
Issue
The affected lots exceed the interim acceptable intake limit for N-nitroso-duloxetine (NDLX).
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional official information
AudienceGeneral public Healthcare Industry
CategoryHealth products - Drugs
CompaniesPharmascience Inc. 6111, av. Royalmount, Suite 100 Montréal, Québec H4P 2T4
Published byHealth Canada
Recall classType I
Alert / recall typeHealth product recall
Identification numberRA-75398
Background{}
CompaniesPharmascience Inc. 6111, av. Royalmount, Suite 100 Montréal, Québec H4P 2T4
AudiencesGeneral public Healthcare Industry
Source updated2024-04-17
Contains information licensed under the Open Government Licence – Canada. SafetyPulse is independent of the Government of Canada.
FAQ
Frequently asked questions
Answers based on the official recall notice.
Product images
Official product images from Health Canada.
Starting...
Explore more
Related recalls
Similar recalls and safety notices.